Vistagen Therapeutics (NASDAQ:VTGN) Posts Earnings Results, Beats Expectations By $0.01 EPS
Vistagen Therapeutics (NASDAQ:VTGN) issued its earnings results on Thursday. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.14) by $0.01, Fidelity Earnings reports.
VTGN stock opened at $1.08 on Friday. Vistagen Therapeutics has a 1-year low of $0.38 and a 1-year high of $2.06. The company has a market capitalization of $46.20 million, a P/E ratio of -1.20 and a beta of -0.29. The company has a debt-to-equity ratio of 2.44, a current ratio of 2.65 and a quick ratio of 2.65. The business has a 50-day moving average price of $1.15 and a 200 day moving average price of $0.83.
A number of analysts have recently issued reports on the stock. Chardan Capital reissued a “hold” rating and set a $0.70 target price on shares o ...